FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Chaney

Research Profile

Chemicals & Drugs

Physiology

Living Beings

Anatomy

Tumor Cells, Cultured

Concepts & Ideas

Kinetics

Disorders

Co-author Network

Publications

TOP 3
Srinivas Ramachandran; Brenda Temple; Anastassia N Alexandrova; Stephen G Chaney; Nikolay V Dokholyan
Recognition of platinum-DNA adducts by HMGB1a.
Debadeep Bhattacharyya; Gunnar Boysen; Sharon L Campbell; Nikolay V Dokholyan; Candice L King; Wimal Pathmasiri; Srinivas Ramachandran; Shantanu Sharma; James A Swenberg; Irene Baskerville-Abraham; Stephen G Chaney
Flanking bases influence the nature of DNA distortion by platinum 1,2-intrastrand (GG) cross-links.
Irene M Baskerville-Abraham; Gunnar Boysen; J Mitchell Troutman; Esra Mutlu; Leonard Collins; Kathryn E Dekrafft; Wenbin Lin; Candice King; Stephen G Chaney; James A Swenberg
Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Chaney (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Srinivas Ramachandran; Brenda Temple; Anastassia N Alexandrova; Stephen G Chaney; Nikolay V Dokholyan
Recognition of platinum-DNA adducts by HMGB1a.
Biochemistry 2012;51(38):7608-17.
2011: Debadeep Bhattacharyya; Gunnar Boysen; Sharon L Campbell; Nikolay V Dokholyan; Candice L King; Wimal Pathmasiri; Srinivas Ramachandran; Shantanu Sharma; James A Swenberg; Irene Baskerville-Abraham; Stephen G Chaney
Flanking bases influence the nature of DNA distortion by platinum 1,2-intrastrand (GG) cross-links.
PloS one 2011;6(8):e23582.
2009: Irene M Baskerville-Abraham; Gunnar Boysen; J Mitchell Troutman; Esra Mutlu; Leonard Collins; Kathryn E Dekrafft; Wenbin Lin; Candice King; Stephen G Chaney; James A Swenberg
Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.
Chemical research in toxicology 2009;22(5):905-12.
2009: Srinivas Ramachandran; Brenda Temple; Stephen G Chaney; Nikolay V Dokholyan
Structural basis for the sequence-dependent effects of platinum-DNA adducts.
Nucleic acids research 2009;37(8):2434-48.
2009: Sigal Shachar; Omer Ziv; Sharon Avkin; Sheera Adar; John Wittschieben; Thomas Reissner; Stephen G Chaney; Errol C Friedberg; Zhigang Wang; Thomas Carell; Nicholas Geacintov; Zvi Livneh
Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals.
The EMBO journal 2009;28(4):383-93.
2007: Shantanu Sharma; Peng Gong; Brenda Temple; Debadeep Bhattacharyya; Nikolay V Dokholyan; Stephen G Chaney
Molecular dynamic simulations of cisplatin- and oxaliplatin-d(GG) intrastand cross-links reveal differences in their conformational dynamics.
Journal of molecular biology 2007;373(5):1123-40.
2007: Yibing Wu; Debadeep Bhattacharyya; Candice L King; Irene Baskerville-Abraham; Sung-Ho Huh; Gunnar Boysen; James A Swenberg; Brenda Temple; Sharon L Campbell; Stephen G Chaney
Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.
Biochemistry 2007;46(22):6477-87.
2006: Sharon Avkin; Ziv Sevilya; Leanne Toube; Nicholas Geacintov; Stephen G Chaney; Moshe Oren; Zvi Livneh
p53 and p21 regulate error-prone DNA repair to yield a lower mutation load.
Molecular cell 2006;22(3):407-13.
2005: Stephen G Chaney; Sharon L Campbell; Ekaterina Bassett; Yibing Wu
Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
Critical reviews in oncology/hematology 2005;53(1):3-11.
2004: Stephen G Chaney; Sharon L Campbell; Brenda Temple; Ekaterina Bassett; Yibing Wu; Mihir Faldu
Protein interactions with platinum-DNA adducts: from structure to function.
Journal of inorganic biochemistry 2004;98(10):1551-9.
2004: Ekaterina Bassett; Nicole M King; Miriam F Bryant; Suzanne Hector; Lakshmi Pendyala; Stephen G Chaney; Marila Cordeiro-Stone
The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
Cancer research 2004;64(18):6469-75.
2004: Yibing Wu; Padmanava Pradhan; Jody M Havener; Gunnar Boysen; James A Swenberg; Sharon L Campbell; Stephen G Chaney
NMR solution structure of an oxaliplatin 1,2-d(GG) intrastrand cross-link in a DNA dodecamer duplex.
Journal of molecular biology 2004;341(5):1251-69.
2003: Ekaterina Bassett; Alexandra Vaisman; Jody M Havener; Chikahide Masutani; Fumio Hanaoka; Stephen G Chaney
Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
Biochemistry 2003;42(48):14197-206.
2003: Jody M Havener; Stephanie A Nick McElhinny; Ekaterina Bassett; Michele Gauger; Dale A Ramsden; Stephen G Chaney
Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.
Biochemistry 2003;42(6):1777-88.
2002: Ekaterina Bassett; Alexandra Vaisman; Kristen A Tropea; Chad M McCall; Chikahide Masutani; Fumio Hanaoka; Stephen G Chaney
Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
DNA repair 2002;1(12):1003-16.
2002: Stacy S Shord; Stephen A Bernard; Celeste Lindley; Andrew Blodgett; Viral Mehta; Mary Ann Churchel; Michael E Poole; Scott L Pescatore; Feng R Luo; Stephen G Chaney
Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity.
Anticancer research 2002;22(4):2301-9.
2002: Eric Raymond; Sandrine Faivre; Stephen G Chaney; Jan Woynarowski; Esteban Cvitkovic
Cellular and molecular pharmacology of oxaliplatin.
Molecular cancer therapeutics 2002;1(3):227-35.
2002: Sridhar Mani; Martin A Graham; David B Bregman; Percy Ivy; Stephen G Chaney
Oxaliplatin: a review of evolving concepts.
Cancer investigation 2002;20(2):246-63.
2001: Alexandra Vaisman; M W Warren; Stephen G Chaney
The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adducts.
The Journal of biological chemistry 2001;276(22):18999-9005.
2000: Jan Woynarowski; Sandrine Faivre; Maryanne C S Herzig; Brenda Arnett; WG Chapman; Alex V Trevino; E Raymond; Stephen G Chaney; Alexandra Vaisman; M Varchenko; P E Juniewicz
Oxaliplatin-induced damage of cellular DNA.
Molecular pharmacology 2000;58(5):920-7.
2000: Alexandra Vaisman; Stephen G Chaney
The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta.
The Journal of biological chemistry 2000;275(17):13017-25.
2000: Alexandra Vaisman; Chikahide Masutani; Fumio Hanaoka; Stephen G Chaney
Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
Biochemistry 2000;39(16):4575-80.
1999: Stephen G Chaney; Alexandra Vaisman
Specificity of platinum-DNA adduct repair.
Journal of inorganic biochemistry 1999;77(1-2):71-81.
1999: Alexandra Vaisman; Susan E Lim; Steve M. Patrick; William C Copeland; DC Hinkle; John Turchi; Stephen G Chaney
Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.
Biochemistry 1999;38(34):11026-39.
1999: Joyce T Reardon; Alexandra Vaisman; Stephen G Chaney; Aziz Sancar
Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
Cancer research 1999;59(16):3968-71.
1999: Feng R Luo; TY Yen; SD Wyrick; Stephen G Chaney
High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin.
Journal of chromatography. B, Biomedical sciences and applications 1999;724(2):345-56.
1999: Feng R Luo; SD Wyrick; Stephen G Chaney
Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model.
Cancer chemotherapy and pharmacology 1999;44(1):29-38.
1999: Feng R Luo; SD Wyrick; Stephen G Chaney
Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats.
Cancer chemotherapy and pharmacology 1999;44(1):19-28.
1999: Feng R Luo; SD Wyrick; Stephen G Chaney
Biotransformations of oxaliplatin in rat blood in vitro.
Journal of biochemical and molecular toxicology 1999;13(3-4):159-69.
1999: H Ding; M M Goldberg; J H Raymer; J Holmes; JP Stanko; Stephen G Chaney
Determination of platinum in rat dorsal root ganglion using ICP-MS.
Biological trace element research 1999;67(1):1-11.
1998: J Holmes; JP Stanko; M Varchenko; H Ding; Victoria Madden; Charles Bagnell; SD Wyrick; Stephen G Chaney
Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model.
Toxicological sciences : an official journal of the Society of Toxicology 1998;46(2):342-51.
1998: Eric Raymond; Stephen G Chaney; Abdelkrim Taamma; Esteban Cvitkovic
Oxaliplatin: a review of preclinical and clinical studies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(10):1053-71.
1998: Alexandra Vaisman; M Varchenko; Asad Umar; T A Kunkel; John Risinger; J C Barrett; T C Hamilton; Stephen G Chaney
The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.
Cancer research 1998;58(16):3579-85.
1998: Eric Raymond; Sandrine Faivre; Jan Woynarowski; Stephen G Chaney
Oxaliplatin: mechanism of action and antineoplastic activity.
Seminars in oncology 1998;25(2 Suppl 5):4-12.
1998: Feng R Luo; SD Wyrick; Stephen G Chaney
Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells.
Oncology research 1998;10(11-12):595-603.
1997: Alexandra Vaisman; M Varchenko; I Said; Stephen G Chaney
Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity.
Cytometry 1997;27(1):54-64.
1997: D A Delmastro; J Li; Alexandra Vaisman; M Solle; Stephen G Chaney
DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines.
Cancer chemotherapy and pharmacology 1997;39(3):245-53.
1996: L N Petersen; E L Mamenta; T Stevnsner; Stephen G Chaney; Vilhelm A Bohr
Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity.
Carcinogenesis 1996;17(12):2597-602.
1996: Stephen G Chaney; Aziz Sancar
DNA repair: enzymatic mechanisms and relevance to drug response.
Journal of the National Cancer Institute 1996;88(19):1346-60.
1996: Alexandra Vaisman; S Keeney; A F Nichols; S Linn; Stephen G Chaney
Cisplatin-induced alterations in the expression of the mRNAs for UV-damage recognition protein.
Oncology research 1996;8(1):7-12.
1995: D C Thompson; SD Wyrick; David Holbrook; Stephen G Chaney
HPLC and 31P NMR characterization of the reaction between antitumor platinum agents and the phosphorothioate chemoprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721).
Biochemical pharmacology 1995;50(9):1413-9.
1995: D C Thompson; SD Wyrick; David Holbrook; Stephen G Chaney
Effect of the chemoprotective agent WR-2721 on disposition and biotransformations of ormaplatin in the Fischer 344 rat bearing a fibrosarcoma.
Cancer research 1995;55(13):2837-46.
1995: Alexandra Vaisman; Stephen G Chaney
Induction of UV-damage recognition protein by cisplatin treatment.
Biochemistry 1995;34(1):105-14.
1995: D C Thompson; Alexandra Vaisman; M K Sakata; SD Wyrick; David Holbrook; Stephen G Chaney
Organ-specific biotransformation of ormaplatin in the Fischer 344 rat.
Cancer chemotherapy and pharmacology 1995;36(5):439-47.
1995: M Sakata; Stephen G Chaney; D R Spriggs
Possible correlation between ormaplatin biotransformations and neurotoxicity.
Oncology research 1995;7(2):67-71.
1995: D C Thompson; SD Wyrick; David Holbrook; Stephen G Chaney
Effects of anesthetics on ormaplatin biotransformations in the Fischer 344 rat.
Cancer investigation 1995;13(5):555-7.
1994: E L Mamenta; E E Poma; William K Kaufmann; D A Delmastro; H L Grady; Stephen G Chaney
Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
Cancer research 1994;54(13):3500-5.
1994: H Shamkhani; Lucy M Anderson; Cassandra Henderson; T J Moskal; C D Runowicz; L F Dove; A B Jones; Stephen G Chaney; Jerry M Rice; Miriam C Poirier
DNA adducts in human and patas monkey maternal and fetal tissues induced by platinum drug chemotherapy.
Reproductive toxicology (Elmsford, N.Y.) 1994;8(3):207-16.
1994: William P Petros; Stephen G Chaney; David C Smith; J Fangmeier; M Sakata; T D Brown; D L Trump
Pharmacokinetic and biotransformation studies of ormaplatin in conjunction with a phase I clinical trial.
Cancer chemotherapy and pharmacology 1994;33(4):347-54.
1993: W Schmidt; Stephen G Chaney
Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Cancer research 1993;53(4):799-805.
1992: A F Nichols; W J Schmidt; Stephen G Chaney; Aziz Sancar
Limitations of the in vitro repair synthesis assay for probing the role of DNA repair in platinum resistance.
Chemico-biological interactions 1992;81(3):223-31.
1991: G R Gibbons; William K Kaufmann; Stephen G Chaney
Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
Carcinogenesis 1991;12(12):2253-7.
1991: Stephen G Chaney; G R Gibbons; SD Wyrick; P Podhasky
An unexpected biotransformation pathway for tetrachloro-(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in the L1210 cell line.
Cancer research 1991;51(3):969-73.
1991: D C Thomas; I Husain; Stephen G Chaney; G B Panigrahi; I G Walker
Sequence effect on incision by (A)BC excinuclease of 4NQO adducts and UV photoproducts.
Nucleic acids research 1991;19(2):365-70.
1991: D E Chapman; David Holbrook; Stephen G Chaney; Iris H Hall; Kuo-Hsiung Lee
In vivo and in vitro effects of helenalin on mouse hepatic microsomal cytochrome P450.
Biochemical pharmacology 1991;41(2):229-35.
1991: P F Carfagna; A Poma; SD Wyrick; David Holbrook; Stephen G Chaney
Comparisons of tetrachloro(d,l-trans)1,2-diaminocyclohexane-platinum(IV) biotransformations in the plasma of Fischer 344 rats at therapeutic and toxic doses.
Cancer chemotherapy and pharmacology 1991;27(5):335-41.
1991: G R Gibbons; J D Page; Stephen G Chaney
Treatment of DNA with ammonium bicarbonate or thiourea can lead to underestimation of platinum-DNA monoadducts.
Cancer chemotherapy and pharmacology 1991;29(2):112-6.
1991: P F Carfagna; SD Wyrick; David Holbrook; Stephen G Chaney
Effects of diethyldithiocarbamate (DDTC) on the plasma biotransformations of tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in Fischer 344 rats.
Journal of biochemical toxicology 1991;6(1):71-80.
1990: Iris H Hall; A A Grippo; David Holbrook; J J Chang; L M Yang; Stephen G Chaney; Kuo-Hsiung Lee
Renal, hepatic, cardiac and thymic acute toxicity afforded by bis(helenalinyl)malonate in BDF1 mice.
Toxicology 1990;64(2):205-16.
1990: G R Gibbons; J D Page; S K Mauldin; I Husain; Stephen G Chaney
Role of carrier ligand in platinum resistance in L1210 cells.
Cancer research 1990;50(20):6497-501.
1990: C B Oswald; Stephen G Chaney; Iris H Hall
Inhibition of DNA synthesis in P388 lymphocytic leukemia cells of BDF1 mice by cis-diamminedichloroplatinum(II) and its derivatives.
Journal of pharmaceutical sciences 1990;79(10):875-80.
1990: Stephen G Chaney; SD Wyrick; G K Till
In vitro biotransformations of tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in rat plasma.
Cancer research 1990;50(15):4539-45.
1990: P F Carfagna; Stephen G Chaney; J Chang; David Holbrook
Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the Fischer 344 rat.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1990;14(4):706-19.
1990: J D Page; I Husain; Aziz Sancar; Stephen G Chaney
Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality.
Biochemistry 1990;29(4):1016-24.
1990: C B Oswald; Stephen G Chaney; Iris H Hall
Inhibition of nucleic acid synthesis in P388 lymphocytic leukemia cells in culture by cis-platinum derivatives.
Biomedica biochimica acta 1990;49(7):579-87.
1989: D E Chapman; David Holbrook; Stephen G Chaney; Iris H Hall; Kuo-Hsiung Lee
In vitro inhibition of mouse hepatic mixed-function oxidase enzymes by helenalin and alantolactone.
Biochemical pharmacology 1989;38(22):3913-23.
1989: C B Oswald; SD Wyrick; Stephen G Chaney; Robert Shrewsbury; Iris H Hall
Disposition of cisplatin derivatives -3H-cis-1,2-diaminocyclohexanedichloroplatinum (II) and 3H-cis-1,2-diaminocyclohexanemalonatoplatinum (II) in BDF1 mice.
Research communications in chemical pathology and pharmacology 1989;64(1):41-58.
1989: G R Gibbons; SD Wyrick; Stephen G Chaney
Rapid reduction of tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in RPMI 1640 tissue culture medium.
Cancer research 1989;49(6):1402-7.
1988: S K Mauldin; G Gibbons; SD Wyrick; Stephen G Chaney
Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line.
Cancer research 1988;48(18):5136-44.
1988: S K Mauldin; M Plescia; F A Richard; SD Wyrick; R D Voyksner; Stephen G Chaney
Displacement of the bidentate malonate ligand from (d,l-trans-1,2-diaminocyclohexane)malonatoplatinum(II) by physiologically important compounds in vitro.
Biochemical pharmacology 1988;37(17):3321-33.
1988: D E Chapman; G B Roberts; D J Reynolds; A A Grippo; David Holbrook; Iris H Hall; Stephen G Chaney; J Chang; Kuo-Hsiung Lee
Acute toxicity of helenalin in BDF1 mice.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1988;10(2):302-12.
1988: W L Williams; Iris H Hall; A A Grippo; C B Oswald; Kuo-Hsiung Lee; David Holbrook; Stephen G Chaney
Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivo.
Journal of pharmaceutical sciences 1988;77(2):178-84.
1988: Iris H Hall; W L Williams; A A Grippo; Kuo-Hsiung Lee; David Holbrook; Stephen G Chaney
Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones.
Anticancer research 1988;8(1):33-42.
1987: Iris H Hall; A A Grippo; Kuo-Hsiung Lee; Stephen G Chaney; David Holbrook
Effect of helenalin and bis(helenalinyl)malonate on nucleic acid and protein synthesis in human KB carcinoma cells.
Pharmaceutical research 1987;4(6):509-14.
1987: J D Page; Stephen G Chaney; Iris H Hall; Kuo-Hsiung Lee; David Holbrook
Inhibition of inosine monophosphate dehydrogenase by sesquiterpene lactones.
Biochimica et biophysica acta 1987;926(2):186-94.
1987: S D Wyrick; Stephen G Chaney
Re: Effects of bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
Cancer research 1987;47(18):4992.
1986: S K Mauldin; F A Richard; M Plescia; SD Wyrick; Aziz Sancar; Stephen G Chaney
High-performance liquid chromatographic separation of platinum complexes containing the cis-1,2-diaminocyclohexane carrier ligand.
Analytical biochemistry 1986;157(1):129-43.
1986: S K Mauldin; I Husain; Aziz Sancar; Stephen G Chaney
Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
Cancer research 1986;46(6):2876-82.
1985: I Husain; Stephen G Chaney; Aziz Sancar
Repair of cis-platinum-DNA adducts by ABC excinuclease in vivo and in vitro.
Journal of bacteriology 1985;163(3):817-23.
1985: Iris H Hall; W L Williams; Stephen G Chaney; C J Gilbert; David Holbrook; O Muraoka; H Kiyokawa; Kuo-Hsiung Lee
Antitumor agents 68: effects of a series of helenalin derivatives on P-388 lymphocytic leukemia nucleic acid and protein synthesis.
Journal of pharmaceutical sciences 1985;74(3):250-4.
1984: W L Williams; Stephen G Chaney; Iris H Hall; Kuo-Hsiung Lee
Indirect inactivation of rabbit reticulocyte initiation factor eIF-2 by helenalin and bis(helenalinyl) malonate.
Biochemistry 1984;23(23):5637-44.
1984: W Willingham; R T Considine; Stephen G Chaney; Kuo-Hsiung Lee; Iris H Hall
Reversibility of protein synthesis inhibition by quassinoid antineoplastic agents in a rabbit reticulocyte system.
Biochemical pharmacology 1984;33(2):330-3.
1984: Stephen G Chaney; W L Williams; W Willingham; R T Considine; Iris H Hall; Kuo-Hsiung Lee
Inhibition of protein synthesis initiation factors by naturally occurring sulfhydryl reactive reagents.
Current topics in cellular regulation 1984;24():251-60.
1983: W L Williams; Stephen G Chaney; W Willingham; R T Considine; Iris H Hall; Kuo-Hsiung Lee
Selective inactivation of rabbit reticulocyte initiation factor eIF-3 by helenalin.
Biochimica et biophysica acta 1983;740(2):152-62.
1983: Iris H Hall; Y F Liou; Kuo-Hsiung Lee; Stephen G Chaney; W Willingham
Antitumor agents LIX: effects of quassinoids on protein synthesis of a number of murine tumors and normal cells.
Journal of pharmaceutical sciences 1983;72(6):626-30.
1983: R T Considine; W Willingham; Stephen G Chaney; S Wyrick; Iris H Hall; Kuo-Hsiung Lee
Structure-activity relationships for binding and inactivation of rabbit reticulocyte ribosomes by quassinoid antineoplastic agents.
European journal of biochemistry / FEBS 1983;132(1):157-63.
1983: Y F Liou; Iris H Hall; Kuo-Hsiung Lee; W L Williams; Stephen G Chaney
Investigation of sesquiterpene lactones as protein synthesis inhibitors of P-388 lymphocytic leukemia cells.
Biochimica et biophysica acta 1983;739(2):190-6.
1983: S H Reynolds; C K Brantley; J S Harris; Stephen G Chaney
Guanosine 5'-diphosphate 3'-diphosphate levels, carbon source, and ribonucleic acid synthesis in a mutant strain of Escherichia coli.
Biochemistry 1983;22(5):1123-8.
1983: S H Reynolds; Stephen G Chaney
Carbon source transport, nucleotide levels, and stable RNA synthesis in a mutant strain of Escherichia coli.
Archives of biochemistry and biophysics 1983;221(2):548-56.
1983: Delbert Williams; J M Jackson; Stephen G Chaney
Characterization of RNA synthesis in an Escherichia coli mutant with a temperature-sensitive lesion in stable RNA synthesis.
Journal of bacteriology 1983;153(2):616-26.
1982: Y F Liou; Iris H Hall; M Okano; Kuo-Hsiung Lee; Stephen G Chaney
Antitumor agents XLVIII: Structure-activity relationships of quassinoids as in vitro protein synthesis inhibitors of P-388 lymphocytic leukemia tumor cell metabolism.
Journal of pharmaceutical sciences 1982;71(4):430-5.
1982: Iris H Hall; Y F Liou; Kuo-Hsiung Lee; M Okano; Stephen G Chaney
Antitumor agents XLVII: The effects of bisbrusatolyl malonate on P-388 lymphocytic leukemia cell metabolism.
Journal of pharmaceutical sciences 1982;71(2):257-62.
1981: W Willingham; E A Stafford; S H Reynolds; Stephen G Chaney; Kuo-Hsiung Lee; M Okano; Iris H Hall
Mechanism of eukaryotic protein synthesis inhibition by brusatol.
Biochimica et biophysica acta 1981;654(2):169-74.
1978: J S Harris; Stephen G Chaney
Guanine nucleotide metabolism in a mutant strain of Escherichia coli with a temperature sensitive lesion in rRNA synthesis.
Biochimica et biophysica acta 1978;521(2):634-40.
1978: J S Harris; E van Tassel; Stephen G Chaney
A mutation in Escherichia coli that mimics diauxie lag.
Biochemical and biophysical research communications 1978;82(3):982-9.
1977: Stephen G Chaney; J M Jackson; J S Harris
A new mutation affecting ribosomal RNA synthesis in Escherichia coli.
Biochemistry 1977;16(16):3603-7.
1976: J M Jackson; Stephen G Chaney
Escherichia coli mutants with altered ribosomal ribonucleic acid metabolism.
Journal of bacteriology 1976;125(3):1057-73.
1975: Stephen G Chaney; David Schlessinger
Escherichia coli mutants deficient in RNA accumulation at high temperature.
Biochimica et biophysica acta 1975;378(1):80-91.
1972: Stephen G Chaney; J J Duffy; Paul D Boyer
Patterns of oxygen interchange between water, substrates, and phosphate compounds of Escherichia coli and Bacillus subtilis.
The Journal of biological chemistry 1972;247(7):2145-50.
1972: Stephen G Chaney; Paul D Boyer
Incorporation of water oxygens into intracellular nucleotides and RNA. II. Predominantly hydrolytic RNA turnover in Escherichia coli.
Journal of molecular biology 1972;64(3):581-91.
1972: J J Duffy; Stephen G Chaney; Paul D Boyer
Incorporation of water oxygens into intracellular nucleotides and RNA. I. Predominantly non-hydrolytic RNA turnover in Bacillus subtilis.
Journal of molecular biology 1972;64(3):565-79.
1969: Stephen G Chaney; Paul D Boyer
Lack of detection of intermediates in the path of phosphate oxygen to water in photophosphorylation.
The Journal of biological chemistry 1969;244(21):5773-6.